Member Info for bignose58

Oooooo. I just noticed I wrote "Annula report", which, actually is probably not too far from the truth since each year we have been filled with disappointment. Mind you, in hindsight, maybe it would have been more suitably written as "Anal_report"..... :-)

Now I wonder, given the content of the last 24hrs posts, will the proposed "sit down over a beer question and answer time" in a public place still go ahead .......... I'm sure many will be wanting some pretty good in depth explanations, if not more. Good luck to all those who may attend.

Pom et al Apparently what was written in the annual report is a red herring. It would seem that page 29 is part of a broader disclosure of Principal risks and uncertainties facing the Company. When reading this section it is important to read the preamble to it, which is set out on page 27 of the Annual Report. In the preamble it states the following: �Any references below to the Company�s or the Group�s business or products (or any risks in connection with such business or products) include the business or products (and risks in connection with such business or products) of investee companies (including Plethora, in particular Fortacin�) in which the Company or Group has invested in the healthcare and life sciences sectors.� Therefore, while Regent has only one prescription product (Fortacin�) that is being commercialised and to which we are directly seeking marketing authorisations in Plethora�s name in various territories, as previously announced, companies (investee companies) in which RPG have invested may also (now or in the future) be seeking marketing authorisations for their products, the Diabolical Boot Company being just one example. From purely a Regent standpoint though, they do not have any other products that are being developed by Regent (and Plethora) directly as the current attention and efforts are being directed into the continued commercialisation of Fortacin� in the jurisdictions and territories previously announced. So what was the point in including such a dubious paragraph in the AR ? The above has been reworded slightly to prevent sure post removal. Enjoy if you can...... :-(

bunion, Sorry to write that I don't think this will happen since companies like Recordati have in place a network for selling products in and around Europe. It would take them a pretty long time to get a foot in the door and create a network in regions outside of their comfort zone. Hence the need to go with regional companies who have their own regional networks.......a lot of long words there to make it look like I know what Im writing about :-)

Pom, If you manage to read a little of the over 200 pages of the annual report, there is a little on Macau and HK helping with entrance to China. But what help, is anybodies guess . Mind you, if you remember what was originally specified Macau and China and correct me if I�m wrong was initially stated by the end of last year the first time. Just like the FDA, it wasn�t checked properly before making the news release. Same same just like everything else.

Pom Of course it was hidden, the incompetence shown from their previous dates defies belief. This specifically deserved an operational update on its own. Hopefully we will see some return on our investment from a professional body like Recordati since they actually do want to make money for their shareholders. To be honest, We all would have been far better off investing in them once they came on the scene. We have supported the company through thick and thin defending the BOD and upper management here from complete numpies over the years, however. I now concede that they have basically all been correct. The company has not one ounce of empathy towards shareholders investments, otherwise this would have been out there much much sooner if managed correctly with a little forethought, which one needs when it comes to this type of thing. Remember, they all still get paid No matter what.

Since it had been announced that regular meetings with the FDA had occurred a long time back and there have been announced definitive (a few times over) approval dates, non of which have been kept, I too am convinced, as stated previously, of a total lack of understanding of what the FDA required (why else would much earlier dates be explicitly announced unless they were misinterpreted/misunderstood), I for one will def not be staying till the FDA end game. My money has been tied up here far too long feeding what could arguable be a mismanaged debacle. So from start to finish thats about 17 years for FDA approval. That's if they do manage 2022, which Im sure probably wont happen based on the previous track record.

So I had to contact Stella to send me the 2017 Annual report, which I've had a brief look through. (not sure when it was uploaded, but it must be pretty recent since they do include the EU launch dates) Totally disallusioned by their statement on FDA approval not being obtained until late 2021 which means commercial sales not starting till Q1/Q2 2022, if that. Given the content of all previous announcements whereby much earlier years were stated and that early meetings had been had with the FDA and on a continuous basis, all I can say is there has been some major cockups and or very unrealistic reporting of the time lines. Thats only nigh on 9 years since the EU approval for the 20 dose can which is going to be used.....derrrrr.... WTF. Why wasnt the FDA consulted long before. Seems they were too confident on what they thougjht would be the natural route without even consideing to ask the FDA. As Pom had stated before: No wonder China has now come into play. The BS JG fed me in June 2016 about trying to get approval in China would be a nightmare compared to the USA and as such was not being considered was obviously unfounded. Since we may even get the product out there long before we see it in the USA based on the numerous times they have committed dates to paper. This is also probably why there is no sight of any ROW licenses. Prospective licensees want to see an FDA approved product or agreed route before they are willing to commit. I'm sure the previous track record regarding the EU delayed launch has not inspired them wanting to deal with RPG. There appeared to be only 2.25 mill USD cash in the bank (excluding 8mill+ USD other assets) at the end of 2017 which means a good possibility of yet another cash call if EU sales are slow to take off. (I wonder what happened to the remainder of the placing money received in Q1/Q2 (4.93mill USD) and the Q4 milestone payment received (4.71mill USD) = 9.64 - 2.25 = 7.39mill USD spent. Pom your the accountant, if you have the time and the inclination :-) That said, they have also indicated: The Group currently has a number of products for which marketing authorisations have been, will be or are being, sought in various territories. The Group anticipates filing applications to obtain further marketing authorisations in the future......... What products are these ??? Anyone care to guess or point me in the right direction where they are explicitly stated. It is also stated that they are also looking at increasing the batch size yet again. This time from 300L (which apparently equates to 50,000 cans) to 380L (63K cans using a linear relationship, but probably more like 60K) Does this indicate they expect significantly better than expected sales figures since I dont recall seeing any announcement on this before or since ?

Pom Yes, my bad. Cleared........... I'm sure it wont be a serious competitor, although over on IDP, they are jumping for joy. But then they would as they are invested in it. Just as we are jumping for joy.... I mean we were as we have no idea whats going on...LOL

And will users eventually suffer from �white finger� (in this case white dick) ... lol Vibration white finger (VWF), also known as hand-arm vibration syndrome (HAVS) or dead finger, is a secondary form of Raynaud's syndrome, an industrial injury triggered by continuous use of vibrating hand-held machinery.

Any thoughts on prolong by IDP ? Although a mechanical device which is only bought once, it does have FDA approval and is non prescription. There is a sufficient market for several solutions (like the ED market), but I wonder how this product will fare in comparison. Maybe too much hard work to reach a certain level which can be achieved in one app of our solution. I�m sure a lot of patience practicing with it will be needed before it�s effects are noticed ? I�m just curious.

Now I wonder why Recordati are excited if their sales projections are only 20/30 mill. Very small compared to their other products.......unless :-)

If I remember correctly he made similar statements to me 2 years ago which i posted hete and we all know how much egg I got on my face from those empty promises. :-O

And Pfizer initially indicated peak world sales of only 100mill usd for Viagra......Little did they know. Maybe the same will happen here. Little did Recordati know.... One lives in hope :-)

That should read as Vesak.......... I wonder where the extra "e" came from....... it cannot have had anything to do with that well known Northern martial art..."Ecky-Thump" Although my family name hails from the Yorkshire region, we lost the twang tens of years ago. "Eeeeeeeeee by gum" Or even "Eeeee thy dad were a right good baker....". Hovis advert Both must be said in a strong Yorkshire accent. :-)

I notice the HKSX is closed today for the Buddah's birfday (Veseak day).......... Yet: In Singapore this event is not recognized until Tues 29th and according to Wiki: The decision to agree to celebrate Wesākha as the Buddha�s birthday was formalized at the first conference of the World Fellowship of Buddhists held in Sri Lanka in 1950, although festivals at this time in the Buddhist world are a centuries-old tradition. 2018 dates: 29 April (Sri Lanka, Cambodia, Myanmar and Bangladesh) 30 April (India, Nepal) 29 May (Singapore, Thailand, Malaysia and Indonesia) And it doesn't appear to be celebrated officially in China - So why Tuesday 22nd in HK ? Can anyone shed any light on this puzzler ?

Pom I�m sure I read something about this, but never bothered to try n find out much more about it. I wonder why a family held pharmaceutical company would want to let it go. Usually these family concerns are kept in the family.....especially, I would have thought, since they are Italian. I would expect all agreements with all associated products would stay in place if sold and that a big IF. I really wonder what RPG has in mind with respect to the company and/or product. I�m pretty sure there is much closed door discussion going on. I would also expect suitors initially will be offering next to nothing for the product/company and RPG are holding out on the basis that Dr Mike has stated its a blockbuster equal to if not better than Viagra. Which, as we know, has a certain power associated with it. That�s also why we all invested ...is t it.....lol

Pom. Think I'll remind JG of that announcement (once i find it - unless it was in the papers ?) since it was 4 years ago and from term sheet stage to signing doesnt take that long to sort out.

Dingwallgadgie. I was travelling between Singapore and both Indonesia and Malaysia on a weekly basis. Left that particular company after 8years since it and projects were run by incompetent ********s. Got a job working on an FPSO conversion in Singapore, but was sent to China to sort out problems on module supports distorted from welding amongst other things. Ended up at Keppel shit yard ;-) for 6 months responsible for the receipt and heavy lift of the modules on to the vessel. After a year, I left there because the project was run by incompetent managers. Decided to give up work n have an easy life 2 years ago. Miss the work, but def don�t miss the twats who run things. Most engineering was given to Indian companies, who, although gen theoreticallly good, could not apply it in practice. The number of large equipment n pipe supports which were poorly designed as well as primary and secondary structures was unbelievable. I feel sorry for the state of future projects where incompetence will def rule. I�m also surprised there have not been more incidences on operating platforms/structures. (Probably are we just don�t get to hear about them all). Off topic discussion now over ..... lol.

Pom Got an email address ?